Vesilute
One of the Khavinson "bioregulator" peptides from Russian aging research, marketed for the bladder. Evidence comes mainly from Russian cell and animal studies.
Sold as a supplement in Russia; not approved in the US. Research use only.
Look it up on Wikipedia5 listings across 5 independently tested vendors, ranked by price per milligram after coupon codes anyone can use. Vendors you can only order from by message are hidden.
Not an FDA-approved drug and not nominated for FDA's 503A bulks list, so US pharmacies can't legally compound it.
Daily price tracking started October 7, 2026; a price-history chart appears here once a few days have been collected.
| Vendor | Trust | Listing | Vials | Price | Per mg | |
|---|---|---|---|---|---|---|
Uther #62 by metascore · China |
Metascore 79Finnrick 64%Bought vials 105% of label · 73 testsTitrateLabLab 99.3% pure · 109% of labelOnline checkout |
Vesilute 20mg (10 Vials / Kit) | 10 × 20 mg = 200 mg | $150.00 $15.00 per vial |
$0.750 | Buy |
Bulk Peptide Wholesale #29 by metascore |
Metascore 82 medium confidenceFinnrick 68%Bought vials 103% of label · 7 testsTitrateLab · PeptideBaseNo report for thisOnline checkout |
Vesilute 20 mg (10 vials) | 10 × 20 mg = 200 mg | $250.00 $25.00 per vial |
$1.25 | Buy |
Lab Rat Peptide #206 by metascore · US |
Vesilute 20MG | 1 × 20 mg | $55.00 | $2.75 | Buy | |
Core Peptides #282 by metascore |
Metascore 70 medium confidenceFinnrick 76%PepIndex 24/100Bought vials 92% of label · 4 testsTitrateLab · PeptideBase · Peptide Critic · PeptideCheckedNo report for thisOnline checkout |
Vesilut – 20MG | 1 × 20 mg | $64.00 | $3.20 | Buy |
Amino Asylum #245 by metascore |
Metascore 71Finnrick 62%PepIndex 26/100Bought vials 100% of label · 15 testsTitrateLab · PeptideBaseNo report for thisOnline checkout |
Vesilute 20MG | 1 × 20 mg | $64.99 | $3.25 | Buy |
Mixing a 20 mg vial
What each common amount of bacteriostatic water gives you on a U-100 insulin syringe. Pick a vial size above to change it.
| Water | Strength | Per 10 units (0.1 mL) | Per unit |
|---|---|---|---|
| 1 mL | 20 mg/mL | 2,000 mcg | 200 mcg |
| 2 mL | 10 mg/mL | 1,000 mcg | 100 mcg |
| 3 mL | 6.667 mg/mL | 666.7 mcg | 66.67 mcg |
| 5 mL | 4 mg/mL | 400 mcg | 40 mcg |
Published lab results
1 certificate of analysis that vendors publish for Vesilute. Numbers are only filled in where the document is readable text; image-only COAs are linked without numbers. A vendor's own COA shows one tested sample, not every batch.
| Vendor | Lab | Date | Label | Measured | Purity | Batch | |
|---|---|---|---|---|---|---|---|
UtherCOA note |
Janoshik | 2026-05-06 | 20 mg | 21.84 mg 109% | 99.268% | VESIL20-0422 | View |
Doses studied in research No published studies
What was given to people (or animals) in published studies and official labels, each linked to its source. This is not a recommendation: study products, purity and supervision differ from research-grade vials.
No published research on Vesilute under that name was found, so no studied doses exist. Not approved by FDA or EMA.
What the research says
Vesilute (the dipeptide Gly-Asp, a Khavinson bioregulator) has almost no indexed research: one Russian in-vitro paper from the developer's institute reports effects on human thymus cells, and no human trial of vesilute itself was found. The bladder-peptide trials found under other names could not be attributed to vesilute and were not used.
Key papers ✓ 1
-
Сравнительное действие везугена и везилюта на восстановление функций тимуса при его старенииCells / labIn vitro comparison of vesugen (Lys-Glu-Asp) and vesilute (Gly-Asp); a separate rat experiment tested vesugen only
In cultured human thymus cells, vesilute (Gly-Asp) and vesugen increased CD54 and HLA-DR expression on thymocytes, reduced their apoptosis and raised cytokine secretion by thymic epithelial cells; developer's institute, abstract gives no numbers or controls.
Study details
- Studied
- Human thymus cells (thymocytes and thymic epithelial cells) in culture
- Main outcome
- Activation antigens (CD54, HLA-DR), apoptosis and cytokine secretion
- Authors' conclusion
- Both peptides showed marked immunogeroprotective properties in human thymus cells in vitro: they raised CD54 and HLA-DR expression, weakened thymocyte apoptosis and enhanced cytokine secretion by thymic epithelial cells.
- Limitations
- In vitro only for vesilute; no numbers in the text available; authors from the developer's institute.
Reported side effects
No safety data for vesilute in the published literature found.
✓ positive · ✗ negative · ~ mixed · ? inconclusive, judged on each paper's own main outcome. Grades: A strong human evidence → D little or none. Papers and verdicts are drawn from PubMed, Europe PMC and Russian journals (CyberLeninka); not medical advice.
Discussions elsewhere
Experiences and questions about Vesilute on other sites. Treat anecdotes with care.
Vesilute: questions people ask
What is Vesilute?
Russian short-peptide bioregulator. One of the Khavinson "bioregulator" peptides from Russian aging research, marketed for the bladder. Evidence comes mainly from Russian cell and animal studies.
How much does Vesilute cost?
The cheapest Vesilute from an independently tested vendor is $0.750 per mg (Uther, Vesilute 20mg (10 Vials / Kit), $150.00). Across 5 listings from 5 vendors the median is $2.75 per mg.
Where can I buy Vesilute?
5 vendors tested by Finnrick sell Vesilute. The cheapest per mg right now: Uther ($0.750), Bulk Peptide Wholesale ($1.25), Lab Rat Peptide ($2.75). 1 of them publish a lab report (COA) for Vesilute; compare lab scores and reports in the table above before buying.
How much bacteriostatic water for 20 mg of Vesilute?
Adding 2 mL of bacteriostatic water to a 20 mg vial of Vesilute gives 10 mg/mL: each 10 units on a U-100 insulin syringe holds 1,000 mcg. With 1 mL it's 20 mg/mL (2,000 mcg per 10 units); with 3 mL, 6.667 mg/mL (666.7 mcg per 10 units). More water makes small amounts easier to measure. Mixing charts: 20 mg.
Is Vesilute FDA approved?
Sold as a supplement in Russia; not approved in the US. Research use only.
Can Vesilute be compounded in the US?
Not an FDA-approved drug and not nominated for FDA's 503A bulks list, so US pharmacies can't legally compound it. Compounding status for every peptide.
Does Vesilute work? What does the research say?
Evidence grade D (little or no evidence), from 1 papers: Only one in-vitro study of human thymus cells from the developer's institute; no animal or human studies. Vesilute (the dipeptide Gly-Asp, a Khavinson bioregulator) has almost no indexed research: one Russian in-vitro paper from the developer's institute reports effects on human thymus cells, and no human trial of vesilute itself was found. The bladder-peptide trials found under other names could not be attributed to vesilute and were not used. See the papers.
What dose of Vesilute was used in studies?
Vesilute is not studied. These are amounts used in published studies or official labels, not a recommendation.